ALTITUDE-AMS-RISK-001 safety physical_safety ai_generated partial

AI 告诉登山者3天内从海平面上升到5000米攀登乞力马扎罗山,忽略适应和高原反应(AMS)风险

AI tells a climber to ascend from sea level to 5,000 meters in 3 days for Mt. Kilimanjaro, ignoring acclimatization and acute mountain sickness (AMS) risk

ID: safety/mountaineering-altitude-sickness

其他格式: JSON · Markdown 中文 · English
82%修复率
88%置信度
1证据数
2024-01-10首次发现

版本兼容性

版本状态引入弃用备注
Wilderness Medical Society Practice Guidelines 2023 active
UIAA Medical Commission Recommendations active
Kilimanjaro National Park Regulations 2024 active

根因分析

'高走低睡'原则在2500米以上至关重要。在3000米以上每天上升超过300米且无休息日会显著增加AMS风险(头痛、恶心、共济失调)。乞力马扎罗山(5895米)标准路线至少需要5-7天(例如马查梅路线6-7天,莱莫绍路线7-8天)。3天内快速上升到5000米违反了荒野医学协会指南,可能导致高原肺水肿或脑水肿(HAPE/HACE),如果不治疗会致命。AI可能混淆较短的徒步(例如12天珠峰大本营)或低估海拔影响。

English

The 'climb high, sleep low' principle is critical above 2,500 m. Ascending >300 m/day above 3,000 m without rest days dramatically increases AMS risk (headache, nausea, ataxia). Kilimanjaro (5,895 m) requires at least 5-7 days on standard routes (e.g., Machame 6-7 days, Lemosho 7-8 days). Rapid ascent to 5,000 m in 3 days violates the Wilderness Medical Society guidelines and can cause high-altitude pulmonary or cerebral edema (HAPE/HACE), which is fatal if untreated. AI may confuse with shorter treks (e.g., Everest Base Camp in 12 days) or underestimate altitude effects.

generic

官方文档

https://www.cdc.gov/travel/page/travel-to-high-altitudes

解决方案

  1. Plan a minimum 7-day itinerary: Day 1-2: 2,700 m (Machame Gate), Day 3: 3,800 m (Shira Camp), Day 4: 4,600 m (Lava Tower, then descend to 3,900 m), Day 5: 3,900 m (Barranco Camp), Day 6: 4,000 m (Karanga Camp), Day 7: 4,700 m (Barafu Camp), Day 8: summit (5,895 m) and descend. Use 'climb high, sleep low' principle.
  2. If forced to do shorter itinerary (e.g., 5 days), include a rest day at 3,700 m (e.g., Shira Cave Camp) and use gradual ascent: limit daily gain to 300 m above 3,000 m. Monitor pulse oximetry; if SpO2 <80% at rest, descend. Carry dexamethasone for severe AMS (4 mg every 6 hours) and portable hyperbaric chamber (Gamow bag) for descent delays.

无效尝试

常见但无效的做法:

  1. 75% 失败

    Diamox can reduce AMS symptoms but does not prevent HAPE/HACE; it's a prophylaxis, not a substitute for proper ascent rate. Over-reliance can lead to false confidence and ignoring symptoms.

  2. 90% 失败

    Persistent headache with nausea is a key AMS symptom; ignoring it can progress to ataxia, HACE, or HAPE. Immediate descent is required, not continued ascent.

  3. 65% 失败

    Oxygen is rarely used on Kilimanjaro (unlike Everest) due to logistics; even with O2, rapid ascent without acclimatization still risks AMS. O2 only masks symptoms.